Concepedia

Mildred A. Phillipps

MA

Statistics

Publications

7

Citations

327

H-Index

7

Active since

1962

Affiliations

Novartis (Switzerland)(Current)

Mildred A. Phillipps is an author at Novartis (Switzerland) specializing in pharmacology, life sciences, and enzyme inhibition.

Publications per year

1962–1983

7

Publications

7

Isolation and characterization of an enkephalin-degrading aminopeptidase from rat brain

Hans Peter Schnebli, Mildred A. Phillipps, Ralph K. Barclay · Biochimica et Biophysica Acta (BBA) - Enzymology · 1979 · 96 citations

, , +13

Inhibition of enkephalin-degrading aminopeptidase activity by certain peptides

Ralph K. Barclay, Mildred A. Phillipps · Biochemical and Biophysical Research Communications · 1980 · 79 citations

, , +13

Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase

Jon Norman, Justin Ansell, Mildred A. Phillipps · European Journal of Pharmacology · 1983 · 51 citations

, , +7

Inhibition of the enzymatic degradation of leu-enkephalin by puromycin

Ralph K. Barclay, Mildred A. Phillipps · Biochemical and Biophysical Research Communications · 1978 · 45 citations

, , +9

Inhibition by etazolate (SQ 20009) and cartazolate (SQ 65396) of adenosine-stimulated [3H]cAMP formation in [2-3H]adenine-prelabeled vesicles prepared from guinea pig cerebral cortex

Stacy Psychoyos, Mildred A. Phillipps · Biochemical Pharmacology · 1982 · 22 citations

, , +14

1–5 of 7